📖
Increased apoptotic sensitivity of glioblastoma enables therapeutic targeting by BH3-mimetics
Anna Koessinger, Catherine Cloix, Dominik Koessinger, Dieter Henrik Heiland, Florian Bock, Karen Strathdee, Kevin Kinch, Laura Martínez-Escardó, Nikki Paul, Colin Nixon, Gaurav Malviya, Mark Jackson, Kirsteen Campbell, Katrina Stevenson, Sandeep Davis, Yassmin Elmasry, Asma Ahmed, Jim O’prey, Gabriel Ichim, Oliver Schnell, William Stewart, Karen Blyth, Kevin Ryan, Anthony Chalmers, Jim Norman, Stephen Tait

Increased apoptotic sensitivity of glioblastoma enables therapeutic targeting by BH3-mimetics

Science & Mathematics Published 2022 Verification Pending

Overview & Synopsis

Abstract Glioblastoma (GBM) is the most prevalent malignant primary brain tumour in adults. GBM typically has a poor prognosis, mainly due to a lack of effective treatment options leading to tumour persistence or recurrence. We investigated the therapeutic potential of targeting anti-apoptotic BCL-2 proteins in GBM. Levels of anti-apoptotic BCL-xL and MCL-1 were consistently increased in GBM compared with non-malignant cells and tissue. Moreover, we found that relative to their differentiated counterparts, patient-derived GBM stem-like cells also displayed higher expression of anti-apoptotic BCL-2 family members. High anti-apoptotic BCL-xL and MCL-1 expression correlated with heightened susceptibility of GBM to BCL-2 family protein-targeting BH3-mimetics. This is indicative of increased apoptotic priming. Indeed, GBM displayed an obligate requirement for MCL-1 expression in both tumour development and maintenance. Investigating this apoptotic sensitivity, we found that sequential inhibition of BCL-xL and MCL-1 led to robust anti-tumour responses in vivo, in the absence of overt toxicity. These data demonstrate that BCL-xL and MCL-1 pro-survival function is a fundamental prerequisite for GBM survival that can be therapeutically exploited by BH3-mimetics.

Indexed from repository: HAL Open Science (hal.science)
Loading document from verified source...
Keyboard Shortcuts: ← / → for pages • + / - for zoom • 0 to fit width Powered by Mozilla PDF.js v3.11

Document Information

Document Title Increased apoptotic sensitivity of glioblastoma enables therapeutic targeting by BH3-mimetics
Author / Organization Anna Koessinger, Catherine Cloix, Dominik Koessinger, Dieter Henrik Heiland, Florian Bock, Karen Strathdee, Kevin Kinch, Laura Martínez-Escardó, Nikki Paul, Colin Nixon, Gaurav Malviya, Mark Jackson, Kirsteen Campbell, Katrina Stevenson, Sandeep Davis, Yassmin Elmasry, Asma Ahmed, Jim O’prey, Gabriel Ichim, Oliver Schnell, William Stewart, Karen Blyth, Kevin Ryan, Anthony Chalmers, Jim Norman, Stephen Tait
Subject & Discipline Multidisciplinary Academic Open Research
Categories Science & Mathematics
Publication Year 2022
License / Rights Open Access / Creative Commons
Resource Verification Listed PDF (Verification Pending)
Original Host Website HAL Open Science (hal.science)
File Format application/pdf (Portable Document Format)
Language EN
Catalog ID DOC-193784
Original Source Link Visit Source Page on hal.science »